Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.2Revenue (TTM) $M--Net Margin (%)--Altman Z-Score11.8
Enterprise Value $M7.6EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score12.5Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio28.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio28.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-63.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M46.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PTIE is held by these investors:



PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy50,000$3.73-84.72view
FRIEDMANN NADAVCOO 2011-10-18Sell25,000$4.44-87.16view
FRIEDMANN NADAVCOO 2011-10-04Sell25,000$4.81-88.15view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell382,000$4.59-87.58view
FRIEDMANN NADAVCOO 2011-09-15Sell25,000$4.89-88.34view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell44,417$4.2-86.43view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy5,000$4.22-86.49view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell50,000$6.2-90.81view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell28,597$5.69-89.98view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell21,403$5.81-90.19view

Quarterly/Annual Reports about PTIE:

News about PTIE:

Articles On GuruFocus.com
Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE May 13 2015 
Eveillard's First Eagle Increases 2 Positions Sep 11 2014 
Morning Coffee: Real-Time Picks May 14 2014 
Pain Therapeutics Reports Operating Results (10-K) Feb 03 2011 
Pain Therapeutics Reports Operating Results (10-Q) Oct 29 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares Oct 04 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 28,597 Shares Sep 08 2010 
Pain Therapeutics (ptie) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 21,403 Shares Sep 02 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 22,391 Shares Aug 04 2010 
Pain Therapeutics Reports Operating Results (10-Q) Jul 29 2010 

More From Other Websites
Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means Feb 21 2017
Pain Therapeutics reports 4Q loss Feb 17 2017
Pain Therapeutics reports 4Q loss Feb 17 2017
PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 17 2017
Pain Therapeutics Reports 2016 Financial Results Feb 17 2017
Pain Therapeutics to Discuss REMOXY® ER with FDA Dec 20 2016
Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers? Dec 16 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Dec 11 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Dec 08 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 18 2016
Durect (DRRX) Exited Third Quarter with Strong Balance Sheet Nov 01 2016
PAIN THERAPEUTICS INC Financials Oct 29 2016
PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Oct 26 2016
Pain Therapeutics Reports Q3 2016 Financial Results Oct 20 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 20 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Oct 11 2016
Pain Therapeutics (PTIE) Enters Oversold Territory Sep 29 2016
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug Sep 28 2016
Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection Sep 26 2016
5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy Sep 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)